Pediatric hemophagocytic lymphohistiocytosis in a tropical country: Results of a multicenter study in Thailand
Issued Date
2023-04-01
Resource Type
ISSN
17437555
eISSN
17437563
Scopus ID
2-s2.0-85131924182
Pubmed ID
35712989
Journal Title
Asia-Pacific Journal of Clinical Oncology
Volume
19
Issue
2
Start Page
e128
End Page
e137
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asia-Pacific Journal of Clinical Oncology Vol.19 No.2 (2023) , e128-e137
Suggested Citation
Rungrojjananon N., Pakakasama S., Winaichatsak A., Siriwanawong R., Rujkijyanont P., Traivaree C., Photia A., Monsereenusorn C. Pediatric hemophagocytic lymphohistiocytosis in a tropical country: Results of a multicenter study in Thailand. Asia-Pacific Journal of Clinical Oncology Vol.19 No.2 (2023) , e128-e137. e137. doi:10.1111/ajco.13805 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85128
Title
Pediatric hemophagocytic lymphohistiocytosis in a tropical country: Results of a multicenter study in Thailand
Other Contributor(s)
Abstract
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening condition caused by genetic mutation or various triggers disturbing the immune system. Methods: A multicenter retrospective study of pediatric patients with HLH receiving a diagnosis between January 2005 and December 2019 from three pediatric oncology centers was conducted to explore the clinical characteristics and determine prognostic factors associated with outcomes among Thai children. Results: In all, 78 patients with HLH with a median age at diagnosis of 3.17 (range,.08–17.83) years were enrolled. The male to female ratio was 1.2:1. The most common type of HLH was infection-associated hemophagocytic syndrome (IAHS) (n = 59, 75%) of which Epstein-Barr virus was the most common pathogen. Thrombocytopenia, hyperbilirubinemia, and treatment response at weeks 2 and 8 after initiating treatment were associated with mortality. Platelet count <50,000 cells/mm3 was the only independent prognostic factor to define survival outcome (p-value.035). Two-year overall survival rate was 71.3% (95% confidence interval, 59.2%–80.3%). Survival rates between IAHS, malignant associated HLH, macrophage activation syndrome, and unspecific HLH did not significantly differ (p-value.571). Conclusion: IAHS was the most common cause among pediatric HLH in Thailand. The outcomes of Thai children with HLH were comparable to those of developed countries. Platelet count <50,000 cells/mm3 was the only independent prognostic factor to define survival outcome.